Role of obesity on the efficacy of exemestane plus ovarian suppression in hormone receptor-positive premenopausal breast cancer


Nahit Şendur M. A., AKSOY S., Bülent Akinci M., Ozdemir N., ŞENER DEDE D., Altundag K., ...More

Future Oncology, vol.11, no.6, pp.905-907, 2015 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.2217/fon.15.6
  • Journal Name: Future Oncology
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.905-907
  • Keywords: aromatase inhibitors, exemestane, ovarian suppression, premenopausal breast cancer, tamoxifen, BODY-MASS INDEX, ADJUVANT ENDOCRINE THERAPY, PLASMA ESTROGEN-LEVELS, TRIAL, WOMEN, RISK, ANASTROZOLE, LETROZOLE, TAMOXIFEN, AROMATASE
  • Lokman Hekim University Affiliated: No